A prospective study of first-degree relatives of patients with MS found that this high-risk population faces significantly ...

“MASLD and T2DM represent intersecting global epidemics with substantial clinical and public health implications,” wrote the ...

In Perioperative Immunotherapy Advances: Insights from CheckMate-77T and KEYNOTE-671, our panel delves into the following ...

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a ...

Grinspoon noted that even incremental reductions in blood pressure incidence can translate into meaningful declines in ...

Mitochondrial DNA heteroplasmy is independently associated with an increased risk of CLL, suggesting potential as a novel biomarker for early risk identification.

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

EMBRACE reported 12-month suppression rates of 94% (IV N6LS+CAB LA), 82% (SC), and 88% (oral SOC), with no virologic failures and no new clinically significant AEs after month 6. Presentations focused ...

To bridge the gap between clinical exuberance and evidence-based practice, Todd Brown, MD, PhD, an endocrinologist and clinical investigator at Johns Hopkins University, sat down at the Conference on ...

Todd T. Brown, MD, PhD, serves as an endocrinologist and clinical investigator at Johns Hopkins Medical Center. At CROI 2026, experts weigh GLP‑1 drugs in HIV aging—titration tips, surgery precautions ...

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.

Gerald Pierone, MD, serves as the Chief Medical Officer of Whole Family Health Center, where he provides clinical leadership and specializes in the long-term management of HIV.